VJOncology is committed to improving our service to you

ASCO 2019 | Enfortumab vedotin for bladder cancer

VJOncology is committed to improving our service to you

Bradley McGregor

Bradley McGregor, MD, of the Dana-Farber Cancer Institute, Boston, MA discusses enfortumab vedotin for treating bladder cancer. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter